O
RCM

OrbiMed’s R1 RCM Inc. Common Stock RCM Stock Holding History

OrbiMed’s Portfolio RCM Stock Details RCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,803,200
Closed -$50.8M – 127
2023
Q4 		$50.8M Buy
4,803,200
+1,362,200
+40% +$15.4M 1.01% 33
2023
Q3 		$51.9M Hold
3,441,000
– – 1.1% 30
2023
Q2 		$63.5M Buy
3,441,000
+1,691,000
+97% +$27.5M 1.15% 33
2023
Q1 		$26.3M Buy
+1,750,000
New +$23.9M 0.52% 58

Other funds holding RCM

NMC
New Mountain Capital New York $110M AUM 51.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OrbiMed's RCM Position: Q1 2024 in Review

OrbiMed sold out of R1 RCM Inc. Common Stock (RCM) in Q1 2024, closing a stake of 4,803,200 shares — an estimated $50.8M sold.

OrbiMed first reported a position in RCM in Q1 2023 and held it in 4 quarters. The position peaked at $63.5M in Q2 2023. 259 funds tracked by Wall St. Rank hold RCM as of Q1 2024.

  • OrbiMed reported no remaining R1 RCM Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • OrbiMed sold 4,803,200 R1 RCM Inc. Common Stock shares in Q1 2024, an estimated $50.8M.
  • OrbiMed first reported a position in R1 RCM Inc. Common Stock in Q1 2023 and held it in 4 quarters.
  • OrbiMed's R1 RCM Inc. Common Stock position peaked at $63.5M in Q2 2023.
  • 259 funds tracked by Wall St. Rank held R1 RCM Inc. Common Stock as of Q1 2024.

Based on OrbiMed's 13F filing for Q1 2024, filed 15 May 2024.